Sphingolipids are one of the major components of cell membranes and are ubiquitous in eukaryotic organisms. Ceramide 2-aminoethylphosphonate (CAEP) of marine origin is a unique and abundant sphingophosphonolipid with a C-P bond. Although molluscs such as squids and bivalves, containing CAEP, are consumed globally, the dietary efficacy of CAEP is not understood. We investigated the efficacy of marine sphingophosphonolipids by studying the effect of dietary CAEP on the improvement of the skin barrier function in hairless mice fed a diet that induces severely dry-skin condition. The disrupted skin barrier functions such as an increase in the transepidermal water loss (TEWL), a decrease in the skin hydration index, and epidermal hyperplasia were restored by CEAP dietary supplementation. Correspondingly, dietary CAEP significantly increased the content of covalently bound ω-hydroxyceramide, and the expression of its biosynthesis-related genes in the skin. These effects of dietary CAEP mimic those of dietary plant glucosylceramide. The novel observations from this study show an enhancement in the skin barrier function by dietary CAEP and the effects could be contributed by the upregulation of covalently bound ω-hydroxyceramide synthesis in the skin.
The mammalian skin barrier is in the stratum corneum, the outermost layers of the epidermis, which protects against excessive transepidermal water loss (TEWL) and to block of irritants. In this study, we focused on the function to retain water in the epidermis as the skin barrier and the epidermal structures which conducive to the barrier. Lipid lamellae in the extracellular space of corneocytes play a vital role in the barrier function and maintain a hydrophobic environment. These lipids, consisting of 50% ceramides, 25% cholesterol, and 15% fatty acids (on a total lipid mass basis), contribute to the water-holding properties and prevent desiccation by TEWL1,3. Ceramide formation occurs by binding of a fatty acid to an amide group of the sphingoid base. The molecular structures of ceramides are various. Ceramides are essential for the skin barrier function since changes in ceramide profile of the lipid lamellae have been associated with impaired barrier function4,5,6,7,8,9,10.
The structure formed by the binding of ω-hydroxyceramides to cornified envelope proteins is important for the skin barrier11,12. The cornified envelope is a rigid structure with an outer lipid layer and an inner protein, which is produced by the crosslinking of precursor proteins such as involucrin and loricrin13. Ultra-long-chain ceramide participates in the formation of covalently bound ω-hydroxyceramides14,15. The amount of covalently bound ω-hydroxyceramides correlates with skin hydration and skin barrier function11,12,16.
Sphingoid base is a common structure of sphingolipids which are one of the major families of lipids. Since sphingolipids are components of cell membranes, they are ubiquitous in eukaryotic organisms17. However, the polar head groups and ceramide structure of sphingolipids vary among biological species17. For example, sphingomyelin, which has a phosphocholine as a polar head, is a major mammalian sphingophospholipid, and is present in foods such as meat and milk. Glucosylceramide (GluCer) has a glucose as a head group and is a major glycosphingolipid frequently found in not only animals but also higher plants (cereals, beans, and vegetables). A certain quantity of sphingolipids is ingested daily from meals18,23. Recent reports show a protective effect on the skin barrier function by dietary intake of sphingomyelin and GluCer16,24,27. Dietary sphingomyelin and GluCer enhanced mRNA expression of epidermal ceramide synthases (CERS), contributing to ultra-long-chain ceramide synthesis in the dry-skin hairless mouse model26. Sphingoid bases from dietary sphingolipids might participate in the upregulation of epidermal ultra-long-chain ceramide synthesis because sphingoid bases increase the expression of these CERS genes in normal human foreskin keratinocytes26. Earlier studies reported that dietary GluCer is digested intestinally and absorbed as sphingoid bases into the lymph27,29. Additionally, dietary milk phospholipids (consisted mainly of phosphatidylcholine and sphingomyelin) increased epidermal covalently bound ω-hydroxyceramides, and improved skin barrier function in hairless mice16.
In contrast, general marine sphingolipid, ceramide 2-aminoethylphosphonate (CAEP), frequently contains unique structures30. Unlike the C-O-P linkage encountered in the polar head of major sphingophospholipids such as sphingomyelin, the phosphorus atom of 2-aminoethylphosphonate, the polar head of CAEP is directly bound to a carbon atom (C-P bond)30,31. Sphingolipids with C-P bonds, including CAEP, are sphingophosphonolipids30. CAEP consists of not only sphingosine (d18:1) and hexadeca-4-sphingenine (d16:1), often found in mammals, but also a unique triene-type, odd-numbered carbon chain sphingoid base, 2-amino-9-methyl-4,8,10-octadecatriene-1,3-diol (d19:3), which differ from those in mammals32,33,34,35,36,37. The nomenclature for sphingoid bases is to indicate the number of hydroxyl groups (d for di- and t for tri-) followed by the chain length and number of double bonds. CAEP is widely present in marine invertebrates38, including molluscs such as squids39 and bivalves40, consumed globally. Previously, we showed digestion of dietary CAEP to sphingoid bases and absorption of these sphingoid bases, including unique d19:3 into the lymph in experimental animal models41,42. Therefore, dietary CAEP has the potential to improve the skin barrier function via modulation of ceramide synthesis. In the present study, we evaluated the effect of dietary CAEP in comparison with GluCer on the skin barrier function to elucidate its mechanism of action by focusing on the synthesis of covalently bound ω-hydroxyceramides.
Effect on skin properties
After feeding mice HR-AD diet for 11 weeks, severe dry-skin and systemic erythema manifested. A HR-AD diet is used to induce skin damages with dry-skin condition and is especially characterized by a deficiency of magnesium43,45. The dry-skin showed an increase in the TEWL to 18.7 ± 0.9 g/m2/h with a decrease in the hydration index to 24.2 ± 1.3 (arbitrary unit) at the end of HR-AD diet feeding period. The body weight of HR-AD group at the end of HR-AD diet feeding period (day 0 of the recovery treatment period) was 23.1 ± 1.0 g. Daily food intake and body weight were not significantly different among each group during the recovery treatment period (data not shown). After feeding the experimental diet for seven days, tissue weights (liver, spleen, and kidney) were not significantly different among different groups (data not shown). During the recovery treatment period, the dry-skin improved dramatically in all groups. Compared to the control group, TEWL levels on day 3 and 6 of recovery treatment period were reduced significantly by dietary CAEP (Fig. 1A). The hydration index in CAEP and GluCer groups were significantly increased compared to the control group on day 6 of the recovery treatment period (Fig. 1B).
Epidermal hyperplasia was caused by disruption of the skin barrier in mice fed HR-AD diet for 11 weeks. CEAP and GluCer treatment reduced the thickness of epidermal hyperplasia and improved the skin appearance compared to control mice (Fig. 2). Deep wrinkles developed by feeding the HR-AD diet (Fig. 3A). In comparison with the control group, dietary CAEP significantly decreased the number of wrinkles by day 3 of the recovery period (Fig. 3B). In addition, the average depth of wrinkles, wrinkle area ratio, and wrinkle volume ratio were reduced significantly by ingestion of CAEP and GluCer compared to control diet on day 3 of the recovery period (Fig. 3C – E). These results showed accelerated recovery of the skin barrier function and condition by dietary CAEP, in the dry-skin induced by HR-AD diets, comparable to dietary GluCer.
Immunohistochemical staining of skin sections showed involucrin localized to keratinocytes (Fig. 4A). In semi-quantitative assay using immunostaining pictures, the average of percentage areas positive for involucrin immunostaining in adequate area (800–900μm2) of epidermis were 4.9% for HR-AD group, 8.5% for Control group, 16.9% for CAEP group, and 11.6% for GluCer group (n = 2). In CAEP and GluCer groups, the number of keratinocytes was comparable to the control group. In the stratum corneum, the staining intensity of filaggrin was not different among control, CAEP, and GluCer groups (Fig. 4B).
Effect on covalently bound ω-hydroxyceramide synthesis in the skin
Each ceramide molecules structure is shown as “sphingoid base/fatty acid” (“h” placed at numerical symbols of fatty acid means hydroxyl group) with reference to the nomenclature46. The covalently bound ω-hydroxyceramides levels were elevated during the recovery treatment period (Table S1, Fig. 5). Especially, d17:1/32:0 h, d17:1/32:1 h, d17:1/34:1 h, d18:1/32:1 h, and d18:1/34:1 h increased significantly by dietary CAEP and GluCer compared with the HR-AD group. These ω-hydroxyceramide molecules excluding d17:1/32:0 h increased in CAEP and GluCer groups, and d17:1/34:1 h showed a particularly significant change in CAEP group compared with the control group.
Multiple enzymes contribute to the synthesis of covalently bound ω-hydroxyceramide. In this study, dietary CAEP increased mRNA expression of fatty acid elongase (ELOVL4) and ceramide synthases (CERS2 and 3) in the dorsal skin of mice (Fig. 6B–D), especially CERS2 and 3 mRNA expression levels in CAEP group increased significantly than in the HR-AD and control groups (Fig. 6C and D). Additionally, patatin-like phospholipase domain-containing protein 1 (PNPLA1) mRNA expression in CAEP group was significantly higher compared with the HR-AD group (Fig. 6E). PNPLA1 catalyses the synthesis of acylceramide, which is a precursor of covalently bound ω-hydroxyceramide15,47,48. Dietary GluCer significantly upregulated mRNA expression of ELOVL1 and CERS3 in the skin, compared with the HR-AD diet (Fig. 6A and D). These results suggested that dietary CAEP and GluCer promoted the synthesis of covalently bound ω-hydroxyceramides.
Our results show an improvement of skin barrier function by dietary CAEP, and these effects were similar to that of dietary GluCer. The content of CAEP from squids is about 0.2–2% (weight percent of total lipids)39, thus supplementation of CAEP would be useful to achieve the functions. In the present study, the dry-skin condition was produced by feeding HR-AD diet as described earlier47,48. Dietary CAEP enhanced the reduction of TEWL and the increment of the skin hydration index during the recovery treatment period in this model. The epidermal hyperplasia is associated with skin dryness and indicated by the disordered skin barrier49,50. The epidermal thickness in CAEP group from this study closely matches that in normal mature hairless mice HR-1 (approximately 10–15 μm 43). Wrinkles frequently appear due to the dry-skin, such as photodamaged and aged skin, which is closely related to the skin barrier disruption51,54. In these dry-skin conditions, abnormal terminal differentiation of keratinocytes induces the disorder of functional stratum corneum formation that contributes to the skin barrier49,51. The decrease in wrinkles by dietary CAEP might be associated with an improvement in the skin barrier function because dryness influences the skin wrinkles.
Involucrin is present in the granular and upper spinous layers, and earlier clinical reports showed reduced involucrin expression, while premature expression after barrier disruption was observed in lower spinous layer50,55. In this study, the relatively low staining intensity of involucrin tended to be more broadly in the epidermis of HR-AD group compared to the other groups. Since involucrin participates in the maintenance of rigid cornified envelope, involucrin level might contribute to improvement in the skin barrier function13. Additionally, Jensen et al. suggested that decreased involucrin expression may cause a reduction in ω-hydroxyceramide levels in atopic dermatitis (AD) by failing to provide enough substrate for the binding of ceramides50. The immune-stained involucrin in the stratum corneum of CAEP group appeared to be more intense than in other groups, but it was not remarkable. The formation of stratum corneum is related to the upward migration and terminal differentiation of the keratinocytes in the epidermis 13,50,55. To elucidate the effects of dietary sphingolipids, further histological evaluation in detail is required. On the other hand, filaggrin expression was similar among CAEP, GluCer, and control groups. Filaggrin is a specific epidermal protein which is the precursor of the natural moisturizing factors and involved in the stratum corneum hydration56. In the dry-skin, filaggrin expression is downregulated57; however, filaggrin knock-down did not affect lipid composition of stratum corneum58. Hence, suggesting that a shortage of filaggrin participates in dry-skin, although filaggrin knock-down alone does not necessarily affect the barrier function58. Furthermore, Danso et al. reported that ELOVL1 and 6 expressions in the AD patients with filaggrin mutations were comparable to those in the wild-type AD patients59. Therefore, the effect of dietary CAEP on skin barrier function might not involve filaggrin expression changes.
Earlier reports showed a correlation between dry-skin and decrease in covalently bound ω-hydroxyceramide levels16. Covalently bound ω-hydroxyceramides are one of the major components of the cornified lipid envelope14,47,60. The impairment of covalently bound ω-hydroxyceramides production pathway causes ichthyosis47,60. Previous reports mentioned that covalently bound ω-hydroxyceramides are thought to play an important role in stabilizing lamellar structure as compared with other species11,61. In this study, administration of CAEP and GluCer increased epidermal covalently bound ω-hydroxyceramide levels and its synthesis-related gene expression in the skin compared to the control group. We found major covalently bound ω-hydroxyceramides in mice, although the minor molecule species (dihydrosphingosine-type, 4,14-sphingadiene-type and sphingosine-type involving odd-numbered carbon chain fatty acid) indicated by Kawana et al.62 were not detected. Dietary CAEP and GluCer intake effectively restore the skin condition in this mouse model, because ingestion of CAEP and GluCer normalizes the levels of epidermal ω-hydroxyceramide in mice compared to normal, hairless mice (data not shown). Interestingly, dietary CAEP and GluCer increased levels of covalently bound ω-hydroxyceramides having unsaturated fatty acids than those having saturated fatty acids. Previous studies reported that covalently bound ω-hydroxyceramides containing unsaturated fatty acid were less sensitive to aging, seasonal variation, and AD-like damage compared to those containing saturated fatty acid16,61. The presence of an unsaturated acyl chain is necessary for the formation of the lipid lamellar structure63. Importance of covalently bound ω-hydroxyceramides containing unsaturated fatty acid in maintenance and strengthening of epidermal lamellar structures are shown earlier61. In other previous reports, changes in not only covalently bound ω-hydroxyceramides but also epidermal ceramide profile or other lipids content are associated with skin barrier function6,10. Although this study evaluated ω-hydroxyceramides which are significantly associated with dry skin as the first step for elucidation of the effects of dietary CAEP on skin barrier, further studies to evaluate epidermal lipids profiles are needed to elucidate the more detailed mechanism of the effects. Macheleidt et al. reported that epidermal covalently bound ω-hydroxyceramides decreased in atopic dermatitis skin. In earlier reports, it has been shown that sphingomyelin rich diet and dietary GluCer exerted anti-inflammatory effects in the dry-skin hairless mouse model and a mouse model of oxazolone-induced chronic irritant contact dermatitis (ICD), respectively16,64. Therefore, dietary CAEP and GluCer may exert the improving effect on skin barrier function which may be contributed by covalently bound ω-hydroxyceramides synthesis and anti-inflammatory effects also in atopic dermatitis model mice, while this study has not focused on atopic dermatitis cytokines.
In this study, we showed an increase in the level of covalently bound ω-hydroxyceramide in the epidermis by dietary CAEP and GluCer comparable to milk sphingomyelin as reported earlier16. Fatty acids are elongated by the enzymes (ELOVL1-7) which have substrate specificities after conversion to acyl CoA65,66,67. In this study, dietary CAEP increased mRNA expression of ELOVL4, involved in the elongation of ultra-long-chain fatty acids (C26 <), highly expressed in the skin, and essential for skin barrier formation68,69,70,71. In ELOVL4 mutant mice, perinatal death by skin barrier disruption was caused by the deficiency of ultra-long-chain ceramides and acylceramides72,73. On the other hand, dietary GluCer upregulated mRNA expression of ELOVL1 in this study. ELOVL1 is involved in the elongation of very-long-chain fatty acids (especially C20-26) 74. Reports show reduced ELOVL1 mRNA levels in AD lesioned skin59. Sassa et al. showed early death in ELOVL1 knockout mice due to epidermal barrier defects75. Additionally, since C24 < very-long-chain acyl CoA is a substrate for ELOVL4, the upregulation of ELOVL1 might facilitate ultra-long-chain fatty acid synthesis67.
We also showed that dietary CAEP upregulated CERS2 and 3 mRNA expression compared to HR-AD and control groups. CERS3 synthesizes ultra-long-chain ceramide (C26 <), and its deficiency indicates skin barrier defect60,77. CERS2 synthesizes very-long-chain ceramides (C20 <)77,78. Moreover, Jennemann et al. reported that CERS3 uses ultra- but also very-long-chain acyl-CoAs as substrates. Thus, increased expression of ELOVL1 and CERS3 mRNA by dietary GluCer might also contribute to very-long-chain ceramide synthesis.
PNPLA1 plays an essential role in skin barrier function by catalysing the transacylation of the linoleic acid to ultra-long-chain ω-hydroxyceramide for acylceramide production15,43,48. Hydrolysis of the ester bond of oxidized linoleic acid residue of acylceramide produce ω-hydroxyceramide60. Covalently bound ω-hydroxyceramide is formed by crosslinking the exposed ω-OH groups of ω-hydroxyceramide with cornified envelope protein60. Thus, acylceramide is a precursor of covalently bound ω-hydroxyceramide. The enhancement of PNPLA1 mRNA expression by dietary CAEP shown in this study could contribute to improved efficacy of dietary CAEP on skin barrier function. On the other hand, TEWL and wrinkles were improved at day 3, so the expression of mRNAs may increase before the day 3.
An earlier report showed that each sphingoid base such as sphinganine (d18:0), d18:1 and 4,8-sphingadienine (d18:2) similarly enhanced mRNA expression of CERS2-4 in human foreskin keratinocytes26. Sphingatrienine (d18:3) and d19:3, purified from sea star, enhanced the de novo ceramide synthesis and mRNA expression of CERSs and ELOVLs in undifferentiated keratinocytes79. Thus, sphingoid bases derived from CAEP may have a similar effect on skin barrier function. Further investigation is needed to elucidate whether dietary CAEP enhances de novo synthesis of sphingoid bases which can contribute to the improving effect on skin barrier function. Additionally, sphingoid bases (d18:2 and t18:1 (4-hydroxy-8-sphinganine)) facilitated the expression of PPARβ/δ and PPARγ mRNA and acted as a ligand for PPARγ80. Recent studies have shown that activators of PPARα, PPARβ/δ, and PPARγ improved skin barrier function due to increased expression of epidermal ceramide synthesis-related genes and regulation of keratinocyte differentiation81,82,83. Thus, sphingoid bases might induce ceramide synthesis via PPAR activation.
Due to low dietary absorption of sphingoid bases, as shown earlier42, likely, sphingoid bases from dietary sources are hardly reutilized in the skin. However, even a modest delivery of sphingoid bases from dietary CAEP to skin might affect the ceramide synthesis because a low dose of sphingoid bases upregulated CERSs mRNA expression in keratinocytes26. CAEP used in this experiment is composed not only d18:1, which is a principal sphingoid base in mammals, but also unique sphingoid bases d19:3 and d16:1. d19:3 and d16:1 from CAEP were undetectable and d18:1 did not increase in the epidermis after CAEP administration in this study (data not shown). Therefore, suggesting that sphingoid bases derived from dietary sphingolipids are hardly reutilized to form the sphingolipids in the epidermis; however, they or their metabolites might play a role as triggers or signalling molecules in epidermal ceramide synthesis.
In conclusion, the present study shows a novel role of dietary CAEP on the improvement of skin barrier function and its involvement in the synthesis of epidermal covalently bound ω-hydroxyceramide constituted by ultra-long-chain ceramides. Moreover, the upregulation of ultra- and very-long-chain ceramide synthesis by dietary CAEP could contribute to the cornified lipid envelope formation. These effects of dietary CAEP were comparable to the dietary GluCer. The potential of dietary CAEP might be due to its easy digestion and absorption compared to other sphingolipids as described earlier41,42. Sphingoid base composition of maize GluCer was 66.1% d18:2, 13.6% t18:1, and others as described previously29. Structural difference among sphingolipids may affect their degradation and absorption. The findings in this study provide novel insights into the efficacy of dietary marine sphingophosphonolipid.
Materials and methods
Preparation of sphingolipids
CAEP was purified from crude lipids extracted from the skin of jumbo flying squid, Dosidicus gigas, kindly donated by Dr. Saito (Ishikawa Prefectural University, Japan) using previously described methods41. Constituent sphingoid base of the CAEP (purity 98%) were 41.4% d19:3, 28.6% d16:1, 12.9% d18:1, with smaller fractions of others as shown previously41. GluCer prepared from maize was kindly donated by Nippon Flour Mills Co. Ltd. (Atsugi, Japan). The purity of the GluCer was 92%.
Animals and diets
Female hairless mice (Hos: HR-1, 4-week-old) were purchased from Hoshino Laboratory Animals, Inc (Ibaragi, Japan) and maintained following the Guide for the Care and Use of Laboratory Animals (Animal Care Committee, Kyoto University). Approval for all protocols used in this study was from the Kyoto University animal committee (no. 27–37). The mice were individually housed in plastic cages at 24 ± 1 °C with a 12-h light/dark cycle and free access to diet and distilled water. All mice were fed MF standard chow (Oriental Yeast, Tokyo, Japan) for a week, acclimated before the start of the experiments, and were subjected to the experimental protocols as described earlier26. For developing the dry-skin condition (i.e., perturbations in the skin barrier), mice were fed magnesium-deficient diet (HR-AD chow, Nosan Corp., Yokohama, Japan) for 11 weeks47,84. Subsequently, mice were randomly divided into four groups. The mice sacrificed immediately after the HR-AD feeding period were designated as HR-AD group (n = 5). After the HR-AD feeding period, mice in the control group were fed AIN-93G for seven days (n = 5). Mice in the CAEP and GluCer group received the AIN-93G diet containing 0.1% CAEP and 0.1% GluCer, respectively (n = 6 in each group) (Table S2). Body weights and dietary intake of each mouse were measured daily. At the end of each treatment, mice were sacrificed under isoflurane anaesthesia, and the dorsal skin specimens collected immediately. Pieces of dorsal skin were fixed in 10% neutral buffered formalin solution for morphological analysis. To analyse the mRNA expression, part of the skin specimens was stored in RNAlater (Qiagen, Valencia, CA) at − 80 °C until use. The skin specimens for lipid analysis were frozen immediately at − 80 °C.
Measurement of skin barrier functions
TEWL and the dorsal skin hydration index of the mice were measured on day-0, -3, and -6 after switching the HR-AD diet to the experimental diets. The measurements of TEWL and the hydration index by Tewameter TM 300 and Corneometer CM 825 (Courage Khazaka electronic GmbH, Cologne, Germany), respectively, were continued until the TEWL recovered to the normal level (below 10 g/m2/h).
Evaluation of the wrinkles in the skin
On day 0, 3, and 6 of the recovery treatment, the skin surface replicas were collected from the dorsal skin, using a silicone product (Asch Japan Co., Ltd, Hachioji, Japan) under isoflurane anaesthesia. For evaluating the wrinkling degree, parameters (number of wrinkles, the average depth of wrinkles, wrinkle area ratio, and wrinkle volume ratio) of the skin replica were measured using skin wrinkle analysis software (Asch Japan Co., Ltd)52,53.
Histological analysis of epidermis
For evaluating the morphological changes, pieces of dorsal skin were sectioned and stained with haematoxylin and eosin (H&E) by Biopathology Institute (Oita, Japan). Immunohistochemical staining with antibody against involucrin and filaggrin was performed for typical two animals in each group at Biopathology Institute. The thickness of the epidermis and the area of immune-stained involucrin were measured using a Biorevo all-in-one microscope (BZ-9000, Keyence Co., Osaka, Japan) and Image J software (Wayne Rasband, National Institutes of Health, Bethesda, Maryland, USA), respectively. The average value of 10 random determinations was considered as the representative value for the individual animal.
HPLC analysis of covalently bound ceramides in the epidermis
Covalently bound ceramides were extracted with a slight modification of earlier methods12,16. The skin epidermis was separated from the dermis at the basement membrane by overnight incubation at 4 °C with 2.5 U/mL Dispase II (neutral protease, grade II, Roche Diagnostics GmbH Mannheim, Germany) in Hanks' balanced salt solution + (HBSS( +), Nacalai Tesque). After removal of the epidermal lipids using chloroform/methanol (2:1, v/v), ω-hydroxyceramides bound to the stratum corneum by ester bonds were released by overnight incubation in 1 M KOH in 95% methanol at room temperature. Subsequent extraction of ω-hydroxyceramides was with chloroform/methanol (2:1, v/v) after neutralization with acetic acid. The protein level in the residue quantified using a DC Protein Assay kit (Bio-Rad Laboratories, CA, USA). Analysis of ω-hydroxyceramides was done using HPLC system coupled with an ion trap time-of-flight mass-spectrometer (LCMS-IT-TOF; Shimadzu Co., Kyoto, Japan), equipped with atmospheric pressure chemical ionisation (APCI) or electrospray ionisation (ESI) interface (Shimadzu) using an earlier method with some modifications42. Mobile phase A consisted of 1 mM ammonium acetate in methanol and 2 mM ammonium acetate in water (80:20, v/v). Mobile phase B consisted of 1 mM ammonium acetate in methanol and 2 mM ammonium acetate in water (99:1, v/v). The TSKgel ODS-100Z column (2.0 mm × 50 mm, i.d., 3 μm, Tosoh, Tokyo, Japan) was eluted using the following binary gradients: 0–5 min, 50–100% B; 5–35 min, 100% B; 35–40 min, 100–50% B. The MS (range, m/z 400 to 1,200) and MS/MS (range, m/z 200 to 350) spectra were acquired in the positive scan mode. For structural analysis of ω-hydroxyceramides, [M + H – H2O]+ was used to obtain product ions by MS/MS analysis following earlier method36,42. In Table S1, typical signals of d17:1 [M + H – 2H2O]+ (m/z 250.3) and d18:1 [M + H – 2H2O]+ (m/z 264.3), characteristic sphingoid bases present in the mouse skin54 were observed as product ions using auto MS/MS detection mode16. Pairs of structurally-specific product ions of sphingoid bases and their precursor-ions were used to identify ω-hydroxyceramide molecules. The precursor-ions as [M + H – H2O]+ were used to semi-quantify each molecule of ω-hydroxyceramide by LCMS-2010 eV (Shimadzu) equipped with APCI probe. The analytical conditions were as described before with some modifications41. HPLC conditions were like that of LCMS-IT-TOF analysis described above. The relative peak area of ω-hydroxyceramide was calculated using an authentic standard (N-omega-hydroxy-C30:0-D-erythro-ceramide, Matreya LLC, Inc., Pleasant Gap, PA, USA).
RNA preparation and real-time qRT-PCR
Total RNA extraction, cDNA synthesis, and real-time quantitative qPCR were performed as described before with some modifications26,53. Total RNA was extracted from the skin samples in RNAlater by using Sepasol reagent (Nacalai Tesque) following the manufacturer's instructions. cDNAs were synthesized using SuperScript RNase II reverse transcriptase (Invitrogen, CA, USA) with random hexamers. For RT-PCR, 3 μL diluted cDNA was mixed with 7 μL iQ SYBR Green Supermix (Bio-Rad Laboratories, CA, USA) containing 2 μL PCR primer (5 μM, primer sequences are shown in Table S3). Real-time qRT-PCR performed by using a DNA Engine Option system (Bio-Rad Laboratories). The thermal cycling conditions were 3 min at 95 °C for 1 cycle, followed by amplification for 40 cycles with melting for 15 s at 95 °C, and annealing and extension for 30 s at 60 °C. The expression level of each gene was normalized using β-actin (ACTB) mRNA as an internal control.
Data are reported as means ± standard errors. Statistical analysis was by using Stat View software (SAS Institute, NC, USA). Two-way repeated ANOVA analysed body weight and food intake. Analysis of other measurements was by one-way ANOVA and Tukey–Kramer tests as a post hoc test. Data were considered statistically significant with P-values < 0.05.
Breiden, B. & Sandhoff, K. The role of sphingolipid metabolism in cutaneous permeability barrier formation. Biochim. Biophys. Acta. 1841, 441–452 (2014).
Feingold, K. R. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J. Lipid Res. 48, 2531–46 (2007).
Gray, G. M., White, R. J., Williams, R. H. & Yardley, H. J. Lipid composition of the superficial stratum corneum cells of pig epidermis. Br. J. Dermatol. 106, 59–63 (1982).
Motta, S. et al. Ceramide composition of the psoriatic scale. Biochim. Biophys. Acta. 1182, 147–151 (1993).
Motta, S. et al. Abnormality of water barrier function in psoriasis Role of ceramide fractions. Arch. Dermatol. 130, 52–56 (1994).
Yoon, J. S. et al. Alteration of stratum corneum ceramide profiles in spontaneous canine model of atopic dermatitis. Exp. Dermatol. 20, 732–736 (2011).
Franco, J., Ferreira, C., Paschoal Sobreira, T. J., Sundberg, J. P. & HogenEsch, H. Profiling of epidermal lipids in a mouse model of dermatitis: Identification of potential biomarkers. PLoS ONE 13, e0196595. https://doi.org/10.1371/journal.pone.0196595 (2018).
Imokawa, G. et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?. J. Invest. Dermatol. 96, 523–526 (1991).
Di Nardo, A., Wertz, P., Giannetti, A. & Seidenari, S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta. Derm Venereol. 78, 27–30 (1998).
Joo, K. M. et al. Relationship between cutaneous barrier function and ceramide species in human stratum corneum. J. Dermatol. Sci. 60, 47–50 (2010).
Meguro, S., Arai, Y., Masukawa, Y., Uie, K. & Tokimitsu, I. Relationship between covalently bound ceramides and transepidermal water loss (TEWL). Arch. Dermatol. Res. 292, 463–468 (2000).
Macheleidt, O., Kaiser, H. W. & Sandhoff, K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J. Invest. Dermatol. 119, 166–173 (2002).
Kypriotou, M., Huber, M. & Hohl, D. The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the “fused genes” family. Exp. Dermatol. 21, 643–649 (2012).
Muñoz-Garcia, A., Thomas, C. P., Keeney, D. S., Zheng, Y. & Brash, A. R. The importance of the lipoxygenase-hepoxilin pathway in the mammalian epidermal barrier. Biochim. Biophys. Acta. 1841, 401–408 (2014).
Ohno, Y., Kamiyama, N., Nakamichi, S. & Kihara, A. PNPLA1 is a transacylase essential for the generation of the skin barrier lipid ω-O-acylceramide. Nat. Commun. 8, 14610. https://doi.org/10.1038/ncomms14610 (2017).
Morifuji, M. et al. A novel mechanism for improvement of dry skin by dietary milk phospholipids: effect on epidermal covalently bound ceramides and skin inflammation in hairless mice. J. Dermatol. Sci. 78, 224–231 (2015).
Karlsson, K. A. Sphingolipid long chain bases. Lipids 5, 878–891 (1970).
Vesper, H. et al. Critical Review Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J. Nutr. 129, 1239–1250 (1999).
Yunoki, K. et al. Analysis of sphingolipid classes and their contents in meals. Biosci. Biotechnol. Biochem. 72, 222–225 (2008).
Fischbeck, A., Krüger, M., Blaas, N. & Humpf, H. U. Analysis of sphingomyelin in meat based on hydrophilic interaction liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (HILIC-HPLC-ESI-MS/MS). J. Agric. Food Chem. 57, 9469–9474 (2009).
Zeisel, S. H., Char, D. & Sheard, N. F. Choline, phosphatidylcholine and sphingomyelin in human and bovine milk and infant formulas. J. Nutr. 116, 50–58 (1986).
Newburg, D. S. & Chaturvedi, P. Neutral glycolipids of human and bovine milk. Lipids 27, 923–927 (1992).
Sugawara, T. & Miyazawa, T. Separation and determination of glycolipids from edible plant sources by high-performance liquid chromatography and evaporative light-scattering detection. Lipids 34, 1231–1237 (1999).
Tsuji, K. et al. Dietary glucosylceramide improves skin barrier function in hairless mice. J. Dermatol. Sci. 44, 101–107 (2006).
Haruta, Y., Kato, K. & Yoshioka, T. Dietary phospholipid concentrate from bovine milk improves epidermal function in hairless mice. Biosci. Biotechnol. Biochem. 72, 2151–2157 (2008).
Duan, J. et al. Dietary sphingolipids improve skin barrier functions via the upregulation of ceramide synthases in the epidermis. Exp. Dermatol. 21, 448–452 (2012).
Duan, J. et al. Dietary cerebroside from sea cucumber (Stichopus japonicus): absorption and effects on skin barrier and cecal short-chain fatty acids. J. Agric. Food Chem. 64, 7014–7021 (2016).
Sugawara, T., Kinoshita, M., Ohnishi, M., Nagata, J. & Saito, M. Digestion of maize sphingolipids in rats and uptake of sphingadienine by Caco-2 cells. J. Nutr. 133, 2777–2782 (2003).
Sugawara, T. et al. Intestinal absorption of dietary maize glucosylceramide in lymphatic duct cannulated rats. J. Lipid Res. 51, 1761–1769 (2010).
Simon, G. & Rouser, G. Phospholipids of the sea anemone: quantitative distribution; absence of carbon-phosphorus linkages in glycerol phospholipids; structural elucidation of ceramide aminoethylphosphonate. Lipids 2, 55–59 (1967).
Moschidis, M. C. Phosphonolipids. Prog. Lipid Res. 23, 223–246 (1984).
Joseph, J. D. Lipid composition of marine and estuarine invertebrates Part II: mollusca. Prog. Lipid Res. 21, 109–153 (1982).
Irie, A., Kubo, H. & Hoshi, M. Glucosylceramide having a novel tri-unsaturated long-chain base from the spermatozoa of the starfish Asterias amurensis. J. Biochem. 107, 578–586 (1990).
Jin, W., Rinehart, K. L. & Jares-Erijman, E. A. Ophidiacerebrosides: cytotoxic glycosphingolipids containing a novel sphingosine from a sea star. J. Org. Chem. 59, 144–147 (1994).
Ohashi, Y. et al. Squid nerve sphingomyelin containing an unusual sphingoid base. J. Lipid Res. 41, 1118–1124 (2000).
Sugawara, T., Aida, K., Duan, J. & Hirata, T. Analysis of glucosylceramides from various sources by liquid chromatography-ion trap mass spectrometry. J. Oleo. Sci. 59, 387–394 (2010).
Facchini, L., Losito, I., Cataldi, T. R. & Palmisano, F. Ceramide lipids in alive and thermally stressed mussels: an investigation by hydrophilic interaction liquid chromatography-electrospray ionization fourier transform mass spectrometry. J. Mass Spectrom. 51, 768–781 (2016).
Mukhamedova, Kh. S. & Glushenkova, A. I. Natural phosphonolipids. Chem. Nat. Comp. 36, 329–341 (2000).
Saito, H. & Ishikawa, S. Characteristic of lipids and fatty acid compositions of the neon flying squid Ommastrephes bartramii. J. Oleo. Sci. 61, 547–564 (2012).
Hori, T., Arakawa, I. & Sugita, M. Distribution of ceramide 2-aminoethylphosphonate and ceramide aminoethylphosphate (sphingoethanolamine) in some aquatic animals. J. Biochem. 62, 67–70 (1967).
Tomonaga, N., Manabe, Y. & Sugawara, T. Digestion of ceramide 2-aminoethylphosphonate, a sphingolipid from the jumbo flying squid Dosidicus gigas, in mice. Lipids 52, 353–362 (2017).
Tomonaga, N., Tsuduki, T., Manabe, Y. & Sugawara, T. Sphingoid bases of dietary ceramide 2-aminoethylphosphonate, a marine sphingolipid, absorb into lymph in rats. J. Lipid Res. 60, 333–340 (2019).
Fujii, M. et al. Atopic dermatitis-like pruritic skin inflammation caused by feeding a special diet to HR-1 hairless mice. Exp. Dermatol. 14, 460–468 (2005).
Makiura, M. et al. Atopic dermatitis-like symptoms in HR-1 hairless mice fed a diet low in magnesium and zinc. J. Int. Med. Res. 32, 392–399 (2004).
National Research Council (US). Subcommittee on Laboratory Animal Nutrition. Nutrient requirements of laboratory animals, National Academy of Sciences, Washington, D.C., (1995)
Liebisch, G. et al. Shorthand notation for lipid structures derived from mass spectrometry. J. Lipid Res. 54, 1523–1530 (2013).
Elias, P. M. et al. Formation and functions of the corneocyte lipid envelope (CLE). Biochim. Biophys. Acta. 1841, 314–318 (2014).
Hirabayashi, T. et al. PNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis. Nat. Commun. 8, 14609. https://doi.org/10.1038/ncomms14609 (2017).
Denda, M., Sato, J., Tsuchiya, T., Elias, P. M. & Feingold, K. R. Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for seasonal exacerbations of inflammatory dermatoses. J. Invest. Dermatol. 111, 873–878 (1998).
Jensen, J. M. et al. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J. Invest Dermatol. 122, 1423–1431 (2004).
Hashizume, H. Skin aging and dry skin. J. Dermatol. 31, 603–609 (2004).
Urikura, I., Sugawara, T. & Hirata, T. Protective effect of Fucoxanthin against UVB-induced skin photoaging in hairless mice. Biosci. Biotechnol. Biochem. 75, 757–760 (2011).
Komatsu, T., Sasaki, S., Manabe, Y., Hirata, T. & Sugawara, T. Preventive effect of dietary astaxanthin on UVA-induced skin photoaging in hairless mice. PLoS ONE 12, e0171178. https://doi.org/10.1371/journal.pone.0171178 (2017).
Shimada, E., Aida, K., Sugawara, T. & Hirata, T. Inhibitory effect of topical maize glucosylceramide on skin photoaging in UVA-irradiated hairless mice. J. Oleo. Sci. 60, 321–325 (2011).
Ekanayake-Mudiyanselage, S. et al. Expression of epidermal keratins and the cornified envelope protein involucrin is influenced by permeability barrier disruption. J. Invest. Dermatol. 111, 517–523 (1998).
Scott, I. R. & Harding, C. R. Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev. Biol. 115, 84–92 (1986).
Seguchi, T. et al. Decreased expression of filaggrin in atopic skin. Arch. Dermatol. Res.. 288, 442–446 (1996).
van Drongelen, V. et al. Knock-down of filaggrin does not affect lipid organization and composition in stratum corneum of reconstructed human skin equivalents. Exp. Dermatol. 22, 807–712 (2013).
Danso, M. et al. Altered expression of epidermal lipid bio-synthesis enzymes in atopic dermatitis skin is accompanied by changes in stratum corneum lipid composition. J. Dermatol. Sci. 88, 57–66 (2017).
Kihara, A. Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides. Prog. Lipid Res. 63, 50–69 (2016).
Fujiwara, A. et al. Age-related and seasonal changes in covalently bound ceramide content in forearm stratum corneum of Japanese subjects: determination of molecular species of ceramides. Arch. Dermatol. Res. 310, 729–735 (2018).
Kawana, M., Miyamoto, M., Ohno, Y. & Kihara, A. Comparative profiling and comprehensive quantification of stratum corneum ceramides in humans and mice by LC/MS/MS. J. Lipid Res. 61, 884–895 (2020).
Bouwstra, J. A., Gooris, G. S., Dubbelaar, F. E. & Ponec, M. Phase behavior of stratum corneum lipid mixtures based on human ceramides: the role of natural and synthetic ceramide 1. J. Invest. Dermatol. 118, 606–617 (2002).
Yeom, et al. Oral administration of glucosylceramide ameliorates inflammatory dry-skin condition in chronic oxazolone-induced irritant contact dermatitis in the mouse ear. J. Dermatol. Sci. 67, 101–110 (2012).
Nugteren, D. H. The enzymic chain elongation of fatty acids by rat-liver microsomes. Biochim. Biophys. Acta. 106, 280–290 (1965).
Jakobsson, A., Westerberg, R. & Jacobsson, A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog. Lipid Res. 45, 237–249 (2006).
Ohno, Y. et al. ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proc. Natl. Acad. Sci. USA 107, 18439–18444 (2010).
Agbaga, M. P. et al. Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids. Proc. Natl. Acad. Sci. USA 105, 12843–12848 (2008).
Sassa, T. & Kihara, A. Metabolism of very long-chain Fatty acids: genes and pathophysiology. Biomol. Ther. (Seoul) 22, 83–92 (2008).
Mandal, M. N. et al. Characterization of mouse orthologue of ELOVL4: genomic organization and spatial and temporal expression. Genomics 83, 626–635 (2004).
McMahon, A., Butovich, I. A. & Kedzierski, W. Epidermal expression of an Elovl4 transgene rescues neonatal lethality of homozygous Stargardt disease-3 mice. J. Lipid Res. 52, 1128–1138 (2011).
Cameron, D. J. et al. Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int. J. Biol. Sci. 3, 111–119 (2007).
Vasireddy, V. et al. Loss of functional ELOVL4 depletes very long-chain fatty acids (≥C28) and the unique omega-O-acylceramides in skin leading to neonatal death. Hum. Mol. Genet. 16, 471–482 (2007).
Uchida, Y. The role of fatty acid elongation in epidermal structure and function. Dermatoendocrinol 3, 65–69 (2011).
Sassa, T. et al. Impaired epidermal permeability barrier in mice lacking elovl1, the gene responsible for very-long-chain fatty acid production. Mol. Cell. Biol. 33, 2787–2796 (2013).
Jennemann, R. et al. Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum. Mol. Genet. 21, 586–608 (2012).
Sassa, T., Hirayama, T. & Kihara, A. Enzyme activities of the ceramide synthases CERS2-6 are regulated by phosphorylation in the c-terminal region. J. Biol. Chem. 291, 7477–7487 (2016).
Laviad, E. L. et al. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J. Biol. Chem. 283, 5677–5684 (2008).
Mikami, D., Sakai, S., Sasaki, S. & Igarashi, Y. Effects of Asterias amurensis-derived Sphingoid Bases on the de novo ceramide synthesis in cultured normal human epidermal keratinocytes. J. Oleo. Sci. 65, 671–680 (2016).
Shirakura, Y. et al. 4,8-Sphingadienine and 4-hydroxy-8-sphingenine activate ceramide production in the skin. Lipids Health Dis. 11, 108 (2012).
Rivier, M., Castiel, I., Safonova, I., Ailhaud, G. & Michel, S. Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model. J. Invest. Dermatol. 114, 681–687 (2000).
Kömüves, L. G. et al. Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo. J. Invest. Dermatol. 115, 353–360 (2000).
Man, M. Q. et al. Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing. J. Invest. Dermatol. 126, 386–392 (2006).
Ishina, K. et al. Latent essential fatty acid deficiency in a special diet deteriorates skin barrier. Osaka City Med. J. 54, 63–74 (2008).
We thank Dr. Saito and Dr. Itonori for providing valuable materials. This work was supported by JSPS KAKENHI [Grant Numbers JP15J01143, JP16H04923 and JP20H02931].
Nippon Flour Mills Corporation funded this study and provided support for the author T.S. The other authors state no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tomonaga, N., Manabe, Y., Aida, K. et al. Dietary ceramide 2-aminoethylphosphonate, a marine sphingophosphonolipid, improves skin barrier function in hairless mice. Sci Rep 10, 13891 (2020). https://doi.org/10.1038/s41598-020-70888-0